SLP - Simulations Plus • Financials

Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.

Complete and updated financials table with all primary indicators: Net Income, Revenue, EBITDA, Margin, ROE, Dividends

Year	Revenue	EBITDA	Net Inc	Net Mrg	EPS	Equity	ROE	Net Debt Aj	ND/EBITDA Aj	OCF Aj	Capex	FCF	Free Aj	Buyback	Dividend	Payout	DY
08/2016	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
08/2017	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
08/2018	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
08/2019	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
08/2020	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
08/2021	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
08/2022	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
08/2023	60	13	-	17%	0.49	170	6%	-112	-	17	-4	-23	13	-20	-5	48%	0.54%
08/2024	70	12	-	14%	0.49	182	5%	-20	-	7	-4	-7	2	0	-5	48%	0.66%
08/2025	79	-63	-	L	L	125	L	-32	-	12	-4	-1	8	0	0	-	0%

To see all financials—including updated, you must be Premium.